Udayavni Special

Recovered COVID-19 patients may need only one shot of mRNA vaccines, say scientists


PTI, Feb 4, 2021, 12:13 PM IST

Image for Representation

New Delhi: People who have recovered from the novel coronavirus infection may need only one shot as opposed to the recommended two jabs if they are taking the Moderna or Pfizer COVID-19 vaccines, according to a study which suggests ways to minimise doses when supplies are limited.

The yet-to-be peer-reviewed study, posted in the preprint repository medRxiv, assessed the antibody responses in 109 individuals with and without documented pre-existing immunity to the novel coronavirus.

According to the researchers, including Florian Krammer from the Icahn School of Medicine in the US, a single dose of mRNA vaccine elicits very rapid immune responses in individuals already possessing antibodies against the coronavirus from previous exposure to it.

“For individuals with pre-existing immunity to SARS-CoV-2 the first vaccine dose likely immunologically resembles the booster dose in naive individuals,” the scientists wrote in the study.

In the research, the scientists analysed mRNA vaccines which use segments of the viral genetic material to enable human cells to make the coronavirus spike proteins.

These proteins train the immune system of vaccine recipients to fight the actual infectious coronavirus when their body encounters the pathogen.

The scientists said the post-vaccine antibody levels in recovered COVID-19 patients are comparable to, or exceed levels, found in those without prior exposure to the virus who received two vaccinations.

Another yet-to-be peer-reviewed study in medRxiv also studied antibody responses to a single dose of the Pfizer-BioNTech or Moderna vaccines in healthcare workers who had previously recovered from the infection.

It found that their antibody levels started peaking at seven days since immunisation, and achieved higher titers and neutralisation in 14 days compared to volunteers exposed to the vaccine for the first time.

“Although we did not have peak titers for these individuals after natural infection, the titers developed after single vaccination was higher than peak titers in inpatients and outpatients with COVID-19, similar to what has been described in primary vaccination after two doses of the spike-based mRNA vaccines,” the researchers wrote in the study.

According to the scientists from the University of Maryland School of Medicine in the US, the secondary response occurs through activation of the immune system’s memory B cells.

Based on the findings, the researchers recommend a strategy of single dose vaccination for patients who have already had laboratory-confirmed COVID-19.

They said those who have recovered from the disease can be placed lower on the vaccination priority list.

Commenting on the two studies, Eleanor Riley, Professor of Immunology and Infectious Disease at the University of Edinburgh in the UK, said the findings are “very reassuring”, adding that the vaccines are “very effectively boosting the immunity induced by infection.”

While the two studies suggest that people who have had laboratory-confirmed COVID-19 infection may only require one dose of the vaccine, Riley, who was unrelated to the studies, said incorporating this into a mass vaccination programme may be logistically complex.

He believes it may be safer to ensure that everyone gets two doses.

The preprint platfrom, medRxiv, also cautions that the posted reports are preliminary in nature and have not been certified by peer review.

“They should not be relied on to guide clinical practice or health-related behavior,” it adds.

Lawrence Young, Virologist and Professor of Molecular Oncology, University of Warwick in the UK, believes this question can be resolved with further studies.

“…we should be doing further studies which look at giving previously infected individuals one dose of an mRNA vaccine,” said Young, who was also unrelated to the two studies.

“If future work can confirm this high level of immunity post a single mRNA vaccine in this group of individuals, this could become a viable option when there are concerns around vaccine supply,” he added in a statement.

Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.

Top News

Chitradurga: Dasayya injured in clash with temple preist

Tamil Nadu: DMK-Congress seal seat sharing pact; Cong gets 25 seats

PM Modi dedicates 7,500th Janaushadhi Kendra to nation

Ramesh Jarkiholi Scandal: Woman involved in the video yet to be traced

AAP belongs to Dalits and all those who have no one to fall back upon: Arvind Kejriwal

COVID-19: India records 18,711 new cases

Congress expels 6 workers for raising slogans against Siddaramaiah




Related Articles More

SOPs outlined for vaccination of unregistered healthcare workers, frontline staff

COVID-19: 580 new cases in Karnataka, 5 deaths

‘COVID vaccination at 3,000 centres from Mar 8, target to vaccinate 1.5L people each day’

15L vaccinated against COVID-19 on March 5, highest in a day reports Health Ministry

K’taka COVID-19 update: 677 new cases, 427 discharges, 4 deaths on March 4

MUST WATCH

Crime File Exclusive :ATM Skimming case

There is nothing with Siddaramaiah, except hypocrisy says DV Sadananda Gowda

Udayavani News Bulletin 6-3-21

Opposition is conspiring against us: Bhyrathi Basavaraj

Mangaluru: Jewellery store owner chases, nabs man who fled with gold ring

Latest Additions

Audi to launch electric e-tron range in India in next 2-3 months: Official

Chitradurga: Dasayya injured in clash with temple preist

U’khand: Sudden meeting of BJP core group fuels speculation about major change in govt

Tamil Nadu: DMK-Congress seal seat sharing pact; Cong gets 25 seats

PM Modi dedicates 7,500th Janaushadhi Kendra to nation

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.